News
-
New and certified vegan from TBN
Wednesday | Mar 28 2018COLOUR by TBN has announced that in addition to being certified cruelty-free, the entire cosmetic range is now officially also certified vegan.
-
Clairol Nice ‘n Easy Root Touch-Up
Wednesday | Mar 28 2018CLAIROL Nice'n Easy Root Touch Up is designed to cover root regrowth and greys that show through around the parting, forehead and temples, midway through the haircolour cycle.
-
New enerGi Bio Bars range
Wednesday | Mar 28 2018SET The Bar has officially re-launched its range of professionally formulated sports food products, enerGi Bio Bars, with two additional flavours and new packaging.
-
Dispensary Corner
Wednesday | Mar 28 2018
28 Mar 18CONSPIRACY theorists around the globe have new material for their suspicions, after the publication of a study in the journal Genome Research which detailed tests on a six-inch mummified skeleton from Chile.
-
Interim MA CEO
Wednesday | Mar 28 2018MEDICINES Australia (MA) yesterday announced the appointment of its director of Policy & Research, Elizabeth de Somer (pictured) as the organisation's interim ceo (PD breaking news), subsequent to Milton Catelin's recent resignation.
-
Carroll debunks TGA codeine calculations
Wednesday | Mar 28 2018PROFESSOR Peter Carroll from the University of Sydney has cited "serious concerns" with the Therapeutic Goods Administration's estimate of 100 annual deaths attributed to OTC codeine (PD yesterday), saying the figures do not compare "apples with apples".
-
‘Assessed’ pathway
Wednesday | Mar 28 2018THE TGA's new "assessed listed medicines" pathway for sponsors to enter products in the Australian Register of Therapeutic Goods is now open.
-
Rituximab for CFS?
Wednesday | Mar 28 2018REPORTS that cancer and autoimmune disease drug rituximab could also treat Chronic Fatigue Syndrome (CFS) have been refuted in a new Griffith University study.
-
Some e-cigs toxic
Wednesday | Mar 28 2018SOME e-cigarette liquids are more toxic than nicotine alone, according to US researchers who developed a new testing method and published in PLOS Biology.
-
GSK buy-out of Novartis OTC stake
Wednesday | Mar 28 2018NOVARTIS has announced it will sell its stake in its consumer healthcare joint venture to GSK for US$13.0 billion in cash, to focus on "strategic priorities".
